Business Description
Turk Ilac ve Serum Sanayi
ISIN : TRETRLC00022
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 1.37 | |||||
Interest Coverage | 0.75 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.75 | |||||
Beneish M-Score | -1.72 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 76.3 | |||||
3-Year EBITDA Growth Rate | 47.7 | |||||
3-Year EPS without NRI Growth Rate | 30.5 | |||||
3-Year Book Growth Rate | 105.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.02 | |||||
9-Day RSI | 47.94 | |||||
14-Day RSI | 54.33 | |||||
6-1 Month Momentum % | 77.34 | |||||
12-1 Month Momentum % | 159.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 1.12 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 20.44 | |||||
Days Sales Outstanding | 146.35 | |||||
Days Payable | 55.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.64 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.8 | |||||
Operating Margin % | 7.39 | |||||
Net Margin % | 8.52 | |||||
FCF Margin % | 4.84 | |||||
ROE % | 17.62 | |||||
ROA % | 8.74 | |||||
ROIC % | 9.19 | |||||
ROC (Joel Greenblatt) % | 28.25 | |||||
ROCE % | 34.38 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 64.12 | |||||
PE Ratio without NRI | 84.39 | |||||
PEG Ratio | 1.7 | |||||
PS Ratio | 5.19 | |||||
PB Ratio | 7.33 | |||||
Price-to-Tangible-Book | 6.12 | |||||
Price-to-Free-Cash-Flow | 89.67 | |||||
Price-to-Operating-Cash-Flow | 48.95 | |||||
EV-to-EBIT | 22.83 | |||||
EV-to-EBITDA | 21.24 | |||||
EV-to-Revenue | 4.26 | |||||
EV-to-FCF | 104.52 | |||||
Price-to-Peter-Lynch-Fair-Value | 6.24 | |||||
Price-to-Graham-Number | 4.38 | |||||
Price-to-Net-Current-Asset-Value | 149.1 | |||||
Earnings Yield (Greenblatt) % | 4.38 | |||||
FCF Yield % | 1.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Turk Ilac ve Serum Sanayi Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₺) | 1,206.911 | ||
EPS (TTM) (₺) | 0.558 | ||
Beta | 0 | ||
Volatility % | 66.32 | ||
14-Day RSI | 54.33 | ||
14-Day ATR (₺) | 2.246761 | ||
20-Day SMA (₺) | 29.3 | ||
12-1 Month Momentum % | 159.13 | ||
52-Week Range (₺) | 8.74 - 39.18 | ||
Shares Outstanding (Mil) | 161.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Turk Ilac ve Serum Sanayi Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Turk Ilac ve Serum Sanayi Stock Events
Event | Date | Price(₺) | ||
---|---|---|---|---|
No Event Data |
Turk Ilac ve Serum Sanayi Frequently Asked Questions
What is Turk Ilac ve Serum Sanayi(IST:TRILC)'s stock price today?
When is next earnings date of Turk Ilac ve Serum Sanayi(IST:TRILC)?
Does Turk Ilac ve Serum Sanayi(IST:TRILC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |